BridgeMD
New treatment option for Exercise
Official title The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis
ClinicalTrials.gov ID: NCT07320846
What this study is testing
- What it's testing
- The goal of this observational study is to examine the effects of traditional respiratory rehabilitation and respiratory muscle strengthening training added to this program at the genetic level in in patients with rheumatoid arthritis-associated interstitial lung disease. The main questions it aims to answer are: Does respiratory muscle strengthening exercise added to respiratory rehabilitation in patients with rheumatoid arthritis-associated interstitial lung disease have additional benefits on rehabilitation outcome measures such as exercise capacity, shortness of breath, and muscle strength?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75. Healthy volunteers may be eligible.
You may be able to join if
- Diagnosed with RA according to the ACR/EULAR 2010 classification criteria
- Duration of diagnosis greater than 2 years
- Disease activity with a DAS28 score below 5.1
- Voluntary participation in the study
- Presence of lung involvement
You likely can't join if
- Having orthopedic deformities that may affect the treatment program
- Pregnancy
- Uncontrolled diabetes or heart disease
- Participation in a rehabilitation program within the last 6 months
- Body Mass Index (BMI) \> 30
- Patients with severe organ failure
See the full eligibility criteria
- Diagnosed with RA according to the ACR/EULAR 2010 classification criteria
- Duration of diagnosis greater than 2 years
- Disease activity with a DAS28 score below 5.1
- Voluntary participation in the study
- Presence of lung involvement
- Having orthopedic deformities that may affect the treatment program
- Pregnancy
- Uncontrolled diabetes or heart disease
- Participation in a rehabilitation program within the last 6 months
- Body Mass Index (BMI) \> 30
- Patients with severe organ failure
- Recent acute coronary syndrome
- Presence of active infection
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.